Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study

References

• Avila-Funes JA, Amieva H, Barberger-Gateau P, Goff LM, Raoux N, Ritchie K, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc. 2009;57:453–61.
   PubMed Web of Science ®Google Scholar
• Raji MA, Kuo YF, Snih SA, Markides KS, Peek MK, Ottenbacher KJ. Cognitive status, muscle strength, and subsequent disability in older Mexican Americans. J Am Geriatr Soc. 2005;53:1462–8.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738–43.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.
   PubMed Web of Science ®Google Scholar
• Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29:639–58.
   PubMed Web of Science ®Google Scholar
• Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477–83.
   PubMed Web of Science ®Google Scholar
• Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401–7.
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ Open. 2006;332:455–9.
   PubMed Web of Science ®Google Scholar
• Bell JS, Mezrani C, Blacker N, LeBlanc T, Frank O, Alderman CP, et al. Anticholinergic and sedative medicines – prescribing considerations for people with dementia. Aust Fam Physician. 2012;41:45–9.
   PubMed Web of Science ®Google Scholar
• Boustani M, Hall KS, Lane KA, Aljadhey H, Gao S, Unverzagt F, et al. The association between cognition and histamine-2 receptor antagonists in African Americans. J Am Geriatr Soc. 2007;55:1248–53.
   PubMed Web of Science ®Google Scholar
• Campbell NL, Boustani MA, Lane KA, Gao S, Hendrie H, Khan BA, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology. 2010;75:152–9.
   PubMed Web of Science ®Google Scholar
• Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169:1317–24.
   PubMed Web of Science ®Google Scholar
• Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43:1096–106.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Boult C, Artz MB, Gross CR, Fillenbaum GG, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26–34.
   PubMed Web of Science ®Google Scholar
• Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22:285–93.
   PubMed Web of Science ®Google Scholar
• Bierman EJ, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman AT. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry. 2007;22:1194–200.
   PubMed Web of Science ®Google Scholar
• Koyama A, Steinman M, Ensrud K, Hillier TA, Yaffe K. Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci. 2014;69:423–9.
   PubMed Web of Science ®Google Scholar
• Mura T, Proust-Lima C, Akbaraly T, Amieva H, Tzourio C, Chevassus H, et al. Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the Three-city study. Eur Neuropsychopharmacol. 2013;23:212–23.
   PubMed Web of Science ®Google Scholar
• Lagnaoui R, Tournier M, Moride Y, Wolfson C, Ducruet T, Begaud B, et al. The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing. 2009;38:226–8.
   PubMed Web of Science ®Google Scholar
• Dealberto MJ, McAvay GJ, Seeman T, Berkman L. Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry. 1997;12:567–74.
   PubMed Web of Science ®Google Scholar
• Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 2003;60:198–203.
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781–7.
   PubMed Web of Science ®Google Scholar
• Cumming RG, Handelsman D, Seibel MJ, Creasey H, Sambrook P, Waite L, et al. Cohort profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol. 2009;38:374–8.
   PubMed Web of Science ®Google Scholar
• Blyth FM, Rochat S, Cumming RG, Creasey H, Handelsman DJ, Le Couteur DG, et al. Pain, frailty and comorbidity on older men: the CHAMP study. Pain. 2008;140:224–30.
   PubMed Web of Science ®Google Scholar
• Donohoo E. MIMS Annual 2007. Sydney: MIMS Australia, 2007.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, et al. Effects of drug burden index on cognitive function in older men. J Clin Psychopharmacol. 2012;32:273–7.
   PubMed Web of Science ®Google Scholar
• Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58:595–602.
   PubMed Web of Science ®Google Scholar
• Bottai M, Cai B, McKeown RE. Logistic quantile regression for bounded outcomes. Stat Med. 2010;29:309–17.
   PubMed Web of Science ®Google Scholar
• Geraci M. Linear quantile mixed models: the LQMM package for Laplace Quantile Regression. J Stat Softw.2014;57:1–29.
   PubMed Web of Science ®Google Scholar
• Geraci M, Bottai M. Linear quantile mixed models. Stat Comput. 2014;24:461–79.
   Web of Science ®Google Scholar
• R: A language and environment for statistical computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2013.
   Google Scholar
• Jamsen KM, Ilomäki J, Hilmer SN, Jokanovic N, Tan EC, Bell JS. A systematic review of the statistical methods in prospective cohort studies investigating the effect of medications on cognition in older people. Res Social Adm Pharm. 2016;12:20–8.
   PubMed Web of Science ®Google Scholar
• Spencer RJ, Wendell CR, Giggey PP, Katzel LI, Lefkowitz DM, Siegel EL, et al. Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates. Exp Aging Res. 2013;39:382–97.
   PubMed Web of Science ®Google Scholar
• Tangalos EG, Smith GE, Ivnik RJ, Petersen RC, Kokmen E, Kurland LT, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71:829–37.
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, Ling SM, Windham BG, Harris TB, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122:1142–9.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 2011;7:532–9.
   PubMedGoogle Scholar
• Karahalios A, Baglietto L, Lee KJ, English DR, Carlin JB, S JA. The impact of missing data on analyses of a time-dependent exposure in a longitudinal cohort: a simulation study. Emerg Themes Epidemiol. 2013;10:6.
   PubMedGoogle Scholar
• Lee KJ, Carlin JB. Recovery of information from multiple imputation: a simulation study. Emerg Themes Epidemiol. 2012;9:3.
   PubMedGoogle Scholar